The membrane attack complex of complement causes severe demyelination associated with acute axonal injury

被引:166
作者
Mead, RJ
Singhrao, SK
Neal, JW
Lassmann, H
Morgan, BP
机构
[1] Cardiff Univ, Dept Biochem Med, Complement Biol Grp, Cardiff CF14 4XN, S Glam, Wales
[2] Cardiff Univ, Dept Pathol, Complement Biol Grp, Cardiff CF14 4XN, S Glam, Wales
[3] Univ Vienna, Inst Brain Res, Vienna, Austria
关键词
D O I
10.4049/jimmunol.168.1.458
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement is implicated in pathology in the human demyelinating disease multiple sclerosis and in animal models that mimic the demyelination seen in multiple sclerosis. However, the components of the complement system responsible for demyelination in vivo remain unidentified. In this study, we show that C6-deficient (C6(-)) PVG/c rats, unable to form the membrane attack complex (MAC). exhibit no demyelination and significantly reduced clinical score in the Ab-mediated experimental autoimmune encephalomyelitis model when compared with matched C6-sufficient (C6(+)) rats. In C6(+) rats, perivenous demyelination appeared, accompanied by abundant mononuclear cell infiltration and axonal injury. Neither demyelination nor axonal damage was seen in C6(-) rats, whereas levels of mononuclear cell infiltration were equivalent to those seen in C6(+) rats. Reconstitution of C6 to C6(-) rats yielded pathology and clinical disease indistinguishable from that in C6(+) rats. We conclude that demyelination and axonal damage occur in the presence of Ab and require activation of the entire complement cascade, including MAC deposition. In the absence of MAC deposition, complement activation leading to opsonization and generation of the anaphylatoxins; C5a and C3a is insufficient to initiate demyelination.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 48 条
  • [41] Role of complement in the aetiology of Pick's disease?
    Singhrao, SK
    Neal, JW
    Gasque, P
    Morgan, BP
    Newman, GR
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (05) : 578 - 593
  • [42] Phagocytosis of myelin in demyelinative disease: A review
    Smith, ME
    [J]. NEUROCHEMICAL RESEARCH, 1999, 24 (02) : 261 - 268
  • [43] Pathology and pathogenesis of demyelinating diseases
    Storch, M
    Lassmann, H
    [J]. CURRENT OPINION IN NEUROLOGY, 1997, 10 (03) : 186 - 192
  • [44] Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination
    Storch, MK
    Piddlesden, S
    Haltia, M
    Iivanainen, M
    Morgan, P
    Lassmann, H
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (04) : 465 - 471
  • [45] Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide
    vanderLaan, LJW
    Ruuls, SR
    Weber, KS
    Lodder, IJ
    Dopp, EA
    Dijkstra, CD
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1996, 70 (02) : 145 - 152
  • [46] Multiple sclerosis as a neuronal disease
    Waxman, SG
    [J]. ARCHIVES OF NEUROLOGY, 2000, 57 (01) : 22 - 24
  • [47] WURZNER R, 1991, CLIN EXP IMMUNOL, V83, P430
  • [48] MEASUREMENT OF COMPLEMENT COMPONENTS IN CEREBRAL SPINAL-FLUID BY RADIOIMMUNOASSAY IN PATIENTS WITH MULTIPLE-SCLEROSIS
    YAM, P
    PETZ, LD
    TOURTELLOTTE, WW
    MA, BI
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1980, 17 (04): : 492 - 505